BullishAgent BullishAgent
EDGAR Earnings Ratings Insiders Shorts
ETFs Screener Research
Sign in Register
Analyst Ratings · See how every analyst call actually played out — gap, day one through day five, all tracked from the moment the rating hit.
Clear filters
Symbol Sector Firm Action Grade Target Mkt Cap ▼ Base Gap% D1% D2% D3% D4% D5%
AXON Industrials Raymond James Downgrade Strong Buy Outperform $39.8B $196.05 -1.6% -3.5% +0.3% +2.0% +0.7% -0.8%
CHRW Industrials JP Morgan Downgrade Neutral Underweight $20.6B $103.73 -0.9% -2.5% -1.4% +0.1% +1.1% -0.6%
VTRS Healthcare BMO Capital Downgrade Outperform Market Perform $18.9B $11.65 -1.0% +0.3% -1.6% -0.1% +0.4% -0.3%
GNRC Industrials Wells Fargo Downgrade Overweight Equal Weight $14.5B $129.91 -2.2% -2.4% -8.7% +2.5% +2.2% -2.5%
TOST Technology SMBC Nikko Downgrade Outperform Neutral $14.1B $20.03 -0.1% -2.7% +0.3% +3.2% +1.7% -5.1%
TXRH Consumer Cyclical Stifel Downgrade Buy Hold $11.6B $105.15 -4.9% -0.8% +0.2% +1.8% -1.1% -1.3%
XP Financial Services Credit Suisse Downgrade Neutral Underperform $8.9B $15.89 -15.0% -18.8% +3.1% -1.1% +0.5% -2.2%
EPAM Technology TD Cowen Downgrade Outperform Market Perform $5.7B $346.01 -3.2% -2.3% -4.4% -3.7% +0.2% -1.8%
AXTI Technology Craig-Hallum Downgrade Buy Hold $4.6B $5.90 -12.2% -17.3% -9.4% +4.5% +0.4% -3.0%
VC Consumer Cyclical Guggenheim Downgrade Buy Neutral $2.9B $166.23 -0.3% -1.9% -1.3% +2.3% +1.1% -1.4%
COHU Technology Craig-Hallum Downgrade Buy Hold $2.0B $36.59 -1.2% -3.3% -3.2% +0.4% +3.6% +1.2%
INMD Healthcare Needham Downgrade Buy Hold $914M $39.69 -5.4% -6.7% -3.3% +0.7% -0.3% -3.2%
GOOS Consumer Cyclical Evercore ISI Downgrade Outperform In Line $914M $19.96 -2.7% +0.8% -6.2% -0.3% -2.1% -0.7%
PMT Real Estate BTIG Downgrade Buy Neutral $895M $14.25 -2.4% -1.1% -4.5% +0.5% -0.7% -2.1%
APPS Technology Macquarie Downgrade Outperform Neutral $472M $12.83 -3.4% -1.6% -7.3% -0.9% -1.3% -4.8%
UEIC Technology B. Riley Securities Downgrade Buy Neutral $51M $24.45 -18.2% -33.0% -9.6% -3.5% -1.0% -4.5%
UEIC Technology Rosenblatt Downgrade Buy Neutral $51M $24.45 -18.2% -33.0% -9.6% -3.5% -1.0% -4.5%